About Kristina Deligiannidis MD
Dr. Deligiannidis completed her undergraduate degrees and an Honors Scholars Research Program in Neuroscience and Behavior at the University of Massachusetts at Amherst. As a recipient of NIH pre-doctoral Intramural Research Training Awards, she trained in molecular neuroendocrinology research at the National Institutes of Health (NIH).
Dr. Deligiannidis completed additional research training at the NIH during medical school and residency. She received her medical degree from, and completed her psychiatry residency and chief residency in psychopharmacology research at the University of Massachusetts Medical School. Dr. Deligiannidis joined faculty at the Univ. of Massachusetts Medical School in 2009, where she is currently Adjunct Associate Professor of Psychiatry. Dr. Deligiannidis joined faculty at Zucker Hillside Hospital/Feinstein Institute for Medical Research/Hofstra Northwell School of Medicine in September 2016 and is Board Certified by the American Board of Psychiatry and Neurology.
Dr. Deligiannidis is the Director of Women’s Behavioral Health at Zucker Hillside Hospital. She provides consultation and short-term treatment for women suffering from depression or anxiety in pregnancy or during the post-partum period. Her expertise is focused on psychopharmacologic and complementary/alternative treatments for depression and anxiety during the peripartum period including lactation.
Dr. Deligiannidis conducts research in the causes of peripartum depression and on novel therapeutics for depression. Her research interests include:
- Psychoneuroendocrinology (hypothalamic-pituitary-adrenal and gonadal axes, gonadal hormones and neuroactive steroids)
- Neuroimaging and neuroendocrine biomarkers of depression in women during peripartum period
- Gender differences in depression and treatment response
- Complementary and alternative/integrative treatments
Dr. Deligiannidis's research efforts have been nationally recognized. She is the recipient of: a 2013-2018 NIH K23 Career Development Award, 2016 SOBP George Thompson Award for Distinguished Service, 2014 American College of Neuropsychopharmacology (ACNP) Award, 2014-2016 NIH LRP Award, 2012 Research Career Development Institute (CDI) for Psychiatry Award, 2011 UMass Medical School Center for Clinical & Translational Science (CTSA) Pilot Grant, a UMMS Faculty Scholar Award, a 2011 Society for Biological Psychiatry (SOBP) Travel Scholarship Award, a 2010 Worcester Foundation for Biomedical Research Grant; a 2009 NIMH/NCDEU New Investigator Award, APA/APIRE Junior Investigator Awards (2008, 2009) and American Society of Clinical Psychopharmacology/NIMH Clinical Trials in Psychopharmacology Awards (2007, 2008). At UMass Medical School, she received the Early Career Achievement Award in Science and Health (2013) and several teaching awards.
Dr. Deligiannidis actively participates in national scientific committees and gives scientific presentations locally, regionally and nationally. She is an appointed Young Investigator Member of the International Society of Psychoneuroendocrinology (ISPNE), a member of SOBP and a member of the American Society of Clinical Psychopharmacology (ASCP). She serves on the Board of Directors of ASCP, on the Advisory Board for the international journal Acta Psychiatrica Scandinavica and is Chair of the Education Committee for SOBP. She also serves as an ad hoc member of the ACNP Committee on Education & Training and actively serves as a reviewer for the Center for Scientific Review (CSR) at NIH.
Honors and Awards
- Early Career Achievement in Science and Health Award, Women's Faculty Committee, UMass Medical School (2013)
- NIH/NIMH K23 Career Development Award
- University of Pittsburgh/Stanford University Career Development Institute (CDI) for Psychiatry Award (2012)
- Society for Biological Psychiatry (SOBP) Travel Scholarship Award (2011)
- UMass Medical School, Office of Faculty Affairs Faculty Scholar Award (2011)
- UMass Medical School Department of Psychiatry CDRO Research Fellowship Award (2011)
- UMass Center for Clinical & Translational Science Pilot Project Program Grant (2011)
- Worcester Foundation for Biomedical Research Grant (2010)
- NIMH/NCDEU/ASCP New Investigator Award (2009)
- National Network of Depression Centers (NNDC) Annual Scientific Conference Travel Award (2013)
- NIH Early Career Reviewer, Center for Scientific Review (NIH/CSR) 2015
- ACNP (American College of Neuropsychopharmacology) Travel Award (2014)
- SOBP Top Poster Finalist in Clinical/Translational Research (1 of 45/823)(2015)
- SOBP George N. Thompson Award for Distinguished Service (2016)
Department of Psychiatry
University of Massachusetts Medical School
55 Lake Avenue, North
Worcester, Massachusetts 01605
Peripartum neuroactive steroid and gamma-aminobutyric acid profiles in women at-risk ...
UMass Center for Clinical and Translational Science Supported Publications (2016)
Neuroactive steroids (NAS) are allosteric modulators of the gamma-aminobutyric acid (GABA) system. NAS and GABA are implicated in depression. The ...
Pharmacotherapy for Mood Disorders in Pregnancy: A Review of Pharmacokinetic ...
Psychiatry Publications and Presentations (2014)
OBJECTIVE: Pharmacotherapy for mood disorders during pregnancy is often complicated by pregnancy-related pharmacokinetic changes and the need for dose adjustments. ...
Antidepressant augmentation using the N-methyl-D-aspartate antagonist memantine: a randomized, double-blind ...
Psychiatry Publications and Presentations (2013)
OBJECTIVE: Intravenous N-methyl-d-aspartate (NMDA) antagonists have shown promising results in rapidly ameliorating depression symptoms, but placebo-controlled trials of oral NMDA ...
Psychiatry resident/fellow-initiated and -designed multi-modal psychopharmacology curriculum for major ...
Psychiatry Publications and Presentations (2012)
Psychiatric residency programs must train psychiatrists to be proficient in psychopharmacology, despite having a limited number of faculty who are ...
Therapeutic drug monitoring in pregnant and postpartum women: recommendations for ...
Psychiatry Publications and Presentations (2010)
Recently, guidelines for antenatal management of depression were published.1 Psychotherapy alone may be an appropriate treatment for some women, while ...
Posters and Presentations (1)
Disrupted Resting-State Functional Connectivity in Medication-free Women with Postpartum Depression
UMass Center for Clinical and Translational Science Research Retreat (2012)
Background: Women are at increased risk of developing depression in the postpartum, a time of gonadal steroid flux. Abnormalities of ...